Uganda is expected to join three other African countries where an injectable drug has been approved for HIV/AIDS prevention.
Dr. Byamukama told our news reporters that “we have made orders using the Global Fund for [HIV/AIDS, Malaria, and Tuberculosis] for injectable pre-exposure prophylaxis (PrEP). You take one injection every two months. If you are HIV negative, you will not contract HIV.”.
News of the significant development was revealed yesterday by the Uganda Aids Commission (UAC), hailing it as an effective, safe, and more user-friendly disease prevention measure compared to existing options.
Apparently, the long-lasting injectable cabotegravir (CAB-LA) has been confirmed to be effective and is already being considered as key to national efforts to reduce the health burden of HIV/AIDS, which claimed 17,000 lives in Uganda last year.
“We are targeting 10,000 people in the first year, and we are increasing by 10,000 in the subsequent years to benefit from this. But if the need is so high, I promise that we shall make it available,” he said without indicating what criteria will be used to pick the very first beneficiaries.
In conclusion, speaking in an interview in Kampala on Monday, Dr. Daniel Byamukama, head of the HIV prevention division at the Commission, said UAC plans to roll out the drug early next year.
- Police officer among 7 arrested over sale of government drugs
- Mulago hospital gets new capnography to monitor patient breath
written by @enock katamba
- Mr. katamba Enock: Professional designer with experience in web designing who started this activity in 2016 at Kyambogo University. Contact me on : (+256-758287080)
- NationalDecember 7, 2023Police in Tororo District have killed a 26-year-old man, Godfrey Odoi
- EntertainmentDecember 7, 2023Victor Kamenyo advises all his Wife’s admirers to use Soap
- EntertainmentDecember 7, 2023Geosteady discharged from hospital After a four day sickness
- Celebrity GossipDecember 7, 2023Gabie Ntaate speaks about her struggles with Anger issues